These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 5961035)
21. [Findings of the real value of sulphonotherapy in the programs of prevention of leprosy]. Lima Lde S Rev Bras Leprol; 1968-1969; 36(1):31-6. PubMed ID: 5748409 [No Abstract] [Full Text] [Related]
22. Mechanism of action of sulfones. Bergel M Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):89-90. PubMed ID: 7195883 [No Abstract] [Full Text] [Related]
23. The etiology of erythema nodosum leprosum. Pettit JH; Waters MF Int J Lepr Other Mycobact Dis; 1967; 35(1):1-10. PubMed ID: 6067035 [No Abstract] [Full Text] [Related]
24. Treatment of sulphone resistant leprosy--a review of sixty one cases. Seshadri PS; Ravi NT Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123 [No Abstract] [Full Text] [Related]
25. [Prevention of the leprous reaction]. Bergel M Ther Ggw; 1971 Oct; 110(10):1471-6. PubMed ID: 5003860 [No Abstract] [Full Text] [Related]
26. Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch. Rull M; Clayburne G; Sieck M; Schumacher HR Rheumatology (Oxford); 2003 Sep; 42(9):1093-100. PubMed ID: 12777646 [TBL] [Abstract][Full Text] [Related]
28. Comparative tests of glucosulfone sodium (promin), thiocarlid (lsoxyl), and two INH-derivatives with Stefansky-leprosy of the white rat. Meyer-Rohn J Int J Lepr Other Mycobact Dis; 1971; 39(2):354-7. PubMed ID: 5169804 [No Abstract] [Full Text] [Related]
30. [Transition of leprous occular changes under chemotherapy]. Arai M Keisei Geka; 1967 Apr; 10(2):Suppl:7-9. PubMed ID: 6070441 [No Abstract] [Full Text] [Related]
31. Control of leprosy. Lechat MF Lepr Rev; 1969 Oct; 40(4):191-4. PubMed ID: 5385243 [No Abstract] [Full Text] [Related]
32. Treatment of leprosy. Singh RP Indian J Dermatol; 1966 Jul; 11(4):151-2. PubMed ID: 5969952 [No Abstract] [Full Text] [Related]
33. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials. Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577 [TBL] [Abstract][Full Text] [Related]
34. Corticosteroids for treating nerve damage in leprosy. A Cochrane review. van Veen NH; Nicholls PG; Smith WC; Richardus JH Lepr Rev; 2008 Dec; 79(4):361-71. PubMed ID: 19274983 [TBL] [Abstract][Full Text] [Related]
35. [Significance of leprosy in the Central European region]. Hermans EH Internist (Berl); 1966 Dec; 7(12):602 passim. PubMed ID: 4870024 [No Abstract] [Full Text] [Related]
36. Steroid therapy and leprosy. Ramu G Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589 [No Abstract] [Full Text] [Related]
37. Involvement of scalp in leprosy. Mukhopadhyay AK Indian J Lepr; 2005; 77(1):47-50. PubMed ID: 16173419 [TBL] [Abstract][Full Text] [Related]